B-cell malignancy
Showing 1 - 25 of >10,000
B-cell Lymphoma, Non-Hodgkin Lymphoma, B-cell Malignancy Trial (CTX112)
Not yet recruiting
- B-cell Lymphoma
- +7 more
- CTX112
- (no location specified)
Dec 12, 2022
Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)
Not yet recruiting
- Hematopoietic Stem Cell Transplantation
- Hematologic Malignancy
- CliniMACS®
- (no location specified)
Oct 17, 2023
B-cell Malignancy Trial in Sanhe (CD19-CAR-T cells)
Completed
- B-cell Malignancy
- CD19-CAR-T cells
-
Sanhe, Hebei, ChinaHebei Yanda Ludaopei Hospital
Jan 28, 2022
B Cell Malignancy Trial in Sanhe (CD19-STAR-T cells)
Completed
- B Cell Malignancy
- CD19-STAR-T cells
-
Sanhe, Hebei, ChinaHebei Yanda Ludaopei Hospital
Jan 28, 2022
Relapsed or Refractory B-cell Malignancy(NHL/ALL) Trial in Luoyang (ET-02)
Recruiting
- Relapsed or Refractory B-cell Malignancy(NHL/ALL)
- ET-02
-
Luoyang, Henan, China•The First Affiliated Hospital of Henan University of Science an
Aug 26, 2021
Relapsed/Refractory B-cell Malignancies Trial (AC676)
Not yet recruiting
- Relapsed/Refractory B-cell Malignancies
- (no location specified)
Mar 27, 2023
B-cell Malignancy, Low-grade, Non-Hodgkin Lymphoma, Mantle Cell Lymphoma Trial in China (BGB-16673)
Recruiting
- B-cell Malignancy, Low-grade
- +4 more
-
Beijing, Beijing, China
- +8 more
Jul 20, 2022
Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)
Not yet recruiting
- Myeloid Malignancy
- Acute Myeloid Leukemia
-
Cleveland, OhioUniversity Hospitals Seidman Cancer, Case Comprehensive Cancer C
Nov 8, 2023
B Cell Malignancy Trial in Hefei, Suzhou (ThisCART19 cells)
Recruiting
- B Cell Malignancy
- ThisCART19 cells
-
Hefei, Anhui, China
- +1 more
Dec 20, 2021
B-cell Malignancy Trial in Xuzhou (ThisCART22 cells)
Recruiting
- B-cell Malignancy
- ThisCART22 cells
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Nov 9, 2021
B-cell Malignancy Trial in Xuzhou (ThisCART19 cells)
Recruiting
- B-cell Malignancy
- ThisCART19 cells
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Oct 25, 2021
Hematologic Malignancy, Large B-cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Los Angeles (autologous hematopoietic stem
Not yet recruiting
- Hematologic Malignancy
- +5 more
- autologous hematopoietic stem cells added to planned CAR T
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
May 31, 2023
Hematologic Malignancy Trial in Duarte (B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010))
Recruiting
- Hematologic Malignancy
- B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010)
-
Duarte, CaliforniaCity of Hope
Oct 20, 2023
CB-Long-Term Safety Study (CB-LTSS)
Enrolling by invitation
- Lymphoma, Non-Hodgkin
- +7 more
- Allogeneic CAR-T therapy
-
Irvine, California
- +3 more
Nov 18, 2022
Venetoclax Tablets Crushed and Dissolved Into a Solution
Not yet recruiting
- Hematologic Malignancy
- +18 more
- 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Nov 8, 2023
B-cell Leukemia, B-Cell Lymphoma Trial in Uppsala (CAR T cells)
Completed
- B-cell Leukemia
- B-Cell Lymphoma
- CAR T cells
-
Uppsala, SwedenUppsala University Hospital, Dept of Oncology
Oct 14, 2021
B-Cell Lymphoid Malignancies, Hematologic Malignancy, Non-Hodgkin Lymphoma Trial in Miami (Hematopoietic Stem Cells from
Recruiting
- B-Cell Lymphoid Malignancies
- +2 more
- Hematopoietic Stem Cells from HLA-compatible Related
- Hematopoietic Stem Cells from HLA Unrelated
-
Miami, FloridaMiami Cancer Institute at Baptist Health of South Florida
May 5, 2022
Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in Milwaukee
Enrolling by invitation
- Monoclonal Gammopathy of Undetermined Significance
- +6 more
-
Milwaukee, WisconsinAurora Health Care
Jul 20, 2021
Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)
Not yet recruiting
- Hematologic Malignancy
- +21 more
- Fludarabine
- +4 more
- (no location specified)
Feb 9, 2023
B-cell Malignancy, Non-Hodgkin Lymphoma, B-cell Lymphoma Trial in Worldwide (CTX110)
Recruiting
- B-cell Malignancy
- +3 more
- CTX110
-
Los Angeles, California
- +27 more
May 6, 2022
MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular
Recruiting
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- +8 more
-
Boston, Massachusetts
- +6 more
Apr 14, 2022
B-cell Lymphoma, Chronic Lymphocytic Leukaemia, Waldenström Macroglobulinemia Trial in United Kingdom (BI-1206 single agent dose
Completed
- B-cell Lymphoma
- +2 more
- BI-1206 single agent dose escalation phase
- +3 more
-
Leicester, England, United Kingdom
- +4 more
Jun 17, 2021